Am J Transplant, Volume 18, Suppl 3 Archives - Page 48 of 211 - ATC Abstracts

2018 American Transplant Congress
Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy
M. Kleman, R. Detwiler, H. Singh, V. Nickeleit.
University of North Carolina, Chapel Hill, NC.
The purpose of this study is to determine the incidence of rejection and donor specific antibody (DSA) formation after immunosuppression reduction in patients with biopsy…
2018 American Transplant Congress
Clinical Outcomes of Late Conversion to Once-Daily Tacrolimus after Liver Transplant
D. Kim,¹ Y. Jung,¹ J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ M. Kim,¹ S. Kim,¹ D. Joo.¹
¹Surgery, Yonsei University College of Medicine, Seoul, Korea; ²Surgery, Yonsei University Wonju Hospital, Wonju, Korea.
BackgroundSince a once-daily tacrolimus (TAC-OD) has been introduced in the field of transplantation, many studies reported advantages of the new drug, such as the better…
2018 American Transplant Congress
Pre Liver Transplant (LT) Prediction of Surgical Complexity by Recipient Risk Grading and Optimizing Outcomes: The Ochsner Experience
H. Sharma,¹ H. Bohorquez,^1,2 D. Bruce,¹ J. Seal,¹ A. Cohen,^1,2 E. Bugeaud,¹ I. Carmody,^1,2 D. Sonnier,¹ A. Mathur,¹ D. Marroquin,¹ M. Voltz,¹ L. DeGregorio,¹ G. Loss.^1,2
¹Multi-Organ Transplant Institute, Ochsner Health System, New Orleans, LA; ²School of Medicine, University of Queensland, New Orleans, LA.
Background: Ochsner Unit has been assigning the potential recipient with surgical complexity category since 2015 to preempt surgical risk .Aim: To review outcomes after the…
2018 American Transplant Congress
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients
R. Shahbazov,¹ K. Knapp,² S. Tsutsui,² A. Nickkholgh,¹ P. Northup,³ J. Oberholzer,¹ D. Maluf,¹ M. Shiffman,⁴ S. Pelletier.¹
¹Surgery, University of Virginia Healthsystem, Charlottesville, VA; ²University of Virginia School of Medicine, University of Virginia Healthsystem, Charlottesville, VA; ³Gastroenterology, University of Virginia Healthsystem, Charlottesville, VA; ⁴Secours Liver Institute of Richmond, Secours Liver Institute of Richmond, Richmond, VA.
There is a potential to improve patient satisfaction as well as access to liver transplantation (LT). AIM: This study evaluated outcomes of LT recipients whose…
2018 American Transplant Congress
Itraconazole Prophylaxis, Trough Concentration, and Identification of Fungal Pathogens in Lung Transplant
H. Hassouna, V. Athans, K. Brizendine.
Cleveland Clinic Foundation, Cleveland, OH.
Studies of prophylactic itraconazole (ITR) in lung transplant recipients (LTR) are lacking. Our purpose was to evaluate LTR who received ITR prophylaxis and the association…
2018 American Transplant Congress
TLR-Activated Bregs Promote Islet Allograft Tolerance in an IL-10-Independent and TGF-β-Dependent Manner
L. Kojima, K. Lee, K. Deng, H. Tector, C. Dai, S. Kimura, C. Rickert, H. Yeh, J. Markmann.
Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Background: We previously demonstrated the potent capacity of regulatory B cells (Bregs) to mitigate allograft immunity. Recently, we produced TLR-activated B cells in vitro that…
2018 American Transplant Congress
Participation in Paid Work across the Transplant Trajectory from the Perspective of End-Stage-Kidney-Disease Patients
K. Gaudet, M. Achille.
Psychology, University of Montreal, Montreal, QC, Canada.
Purpose: To explore end-stage-kidney-disease patients' experiences of labour participation, from the kidney failure diagnosis to the post-transplant recovery period.Methods: A qualitative research design was adopted.…
2018 American Transplant Congress
Evaluation of a Change in CMV Prevention Strategy Following Pediatric SOT
S. Pangonis, A. Miethke, F. Flores, M. Schecter, S. Kocoshis, D. Lazear, T. Hemmelgam, B. Taylor, G. Paulsen, L. Danziger-Isakov.
Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Optimal cytomegalovirus(CMV) prevention strategy following solid organ transplantation(SOT) is uncertain. We report on CMV disease with implementation of prophylaxis-based prevention with intensive monitoring.We retrospectively evaluated…
2018 American Transplant Congress
Evaluation of Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection in Adult Liver Transplant Recipients
E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, L. Fehrenbacher, D. Kramer.
Aurora St Luke's Medical Center, Milwaukee, WI.
Background: VRE infections are associated with higher morbidity and mortality among patients undergoing liver transplantation.Objective: The primary outcome is to examine the association between Endoscopic…
2018 American Transplant Congress
Evaluation of Risk Factors for Progression of Low Level CMV Viremia in Solid Organ Transplant Recipients
Y. Natori, A. Humar, A. Alghamdi, D. Kumar.
Multi Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Background: Low level CMV viremia is common, and may either progress to higher viral loads that require therapy, or may spontaneously resolve. The clinical predictors…